- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2021–2027 · research · R01
Defining epigenetic mechanisms in NPM1c mutant leukemia
Scott A Armstrong · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2025 · career development · K08
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
Tao Zou · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2027 · research · R01
Development of microRNA (miR)-based cell-targeted polymeric nanoparticles for myeloma therapy
Ruben D Carrasco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R01
Statistical methods for cancer mutational signatures
Giovanni Luigi Parmigiani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2027 · research · R01
Elucidation of the genetic mechanisms driving prostate tumorigenesis through integrative computational and functional approaches
Matthew L Freedman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2027 · grant · D43
BIDIRECTIONAL TRAINING TO ENHANCE CANCER RESEARCH CAPACITY IN AFRICA
Timothy Richard Rebbeck · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2027 · research · R01
Genetic Predisposition to Chronic Lymphocytic Leukemia (CLL)
Jennifer R Brown · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2027 · research · R01
CDK4/6 inhibition during CD8 T cell priming potentiates memory formation in mice and humans
Stephanie Dougan · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R01
Structure-activity relationships governing mammalian SWI/SNF chromatin remodeling activity as a function of chromatin state
Cigall Kadoch · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R01
Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial
Ting Bao · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2027 · career development · K00
Elucidating the Mechanisms of Translational Approaches to Enhance Recovery of Aged Muscle
Jonathan Joseph Petrocelli · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R35
Mechanisms of eIF3-mediated translation regulation
Amy Si-Ying Lee · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2025 · career development · K08
Can a subset of patients with HER2+ metastatic breast cancer be cured?
Heather Anne Parsons · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R37
Targeting vulnerabilities of PPM1D-mutant gliomas
Pratiti Bandopadhayay · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Identification of Metabolic and Immune Deficits in the Aged Population and Their Restoration to Achieve Youthful Anti-Influenza Vaccine Responsiveness
Wayne A. Marasco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2027 · career development · K08
Elucidating the impact of DNA hypomethylation on genome organization and anti-tumor transcriptional programs
Sarah E Johnstone · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R01
Tracing the lineage histories and differentiation trajectories of individual cancer cells in myeloproliferative neoplasms
Sahand Hormoz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2027 · career development · K08
Investigating Transcriptional Elongation and Nuclear RNA Surveillance in Melanoma
Megan Leigh Insco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2024 · cooperative agreement · U01
The construction and utility of reference pan-genome graphs
Heng Li · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Early change in plasma tumor DNA as a patient and trial-level diagnostic in advanced lung cancer
Cloud Peter Paweletz · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · cooperative agreement · U01
A web-based patient-reported symptom monitoring and self-management portal for adolescent and young adult breast cancer survivors
Michelle J. Naughton · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2026 · career development · K00
Perturbation based single cell investigation of tumor micro-environment
Chi Zhang · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R00
Interrogating and rewiring cell signaling pathways in CAR-T cells with synthetic phosphotyrosine recognition domains
Xin Zhou · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · career development · K23
Determining Mechanisms and Measures for the Design of Chemotherapy-Induced Peripheral Neuropathy Clinical Trials in Adolescents and Young Adults with Cancer
Robert James Knoerl · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020 · research · R01
Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches
Andy Sl Tan · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · program · P50
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant
Cesar M Castro · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Characterizing the LINE-1 Retrotransposition-Replication Conflict
Kathleen H Burns · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · career development · K08
Enhancing Venetoclax Activity in Chemoresistant Acute Myeloid Leukemia
Jacqueline Suen Garcia · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2022 · career development · K99
Mechanistic characterization of the anti-inflammatory function of thermogenic fat for the treatment of metabolic disorders
Evanna Louisa Mills · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2024 · career development · K99
Uncovering Principles of Adaptive Regulation in Cancer Resistance Through Deep Evolutionary Profiling
Arvind Ravi · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R00
Deep clinical trajectory modeling to optimize accrual to cancer clinical trials
Kenneth L Kehl · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
NMR Fingerprinting: Leveraging optimal control pulse design, tailored isotope labeling, and machine learning to study intractable proteins
Haribabu Arthanari · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
Next Generation Computational Tools for Functional Genomics
Rafael Angel Irizarry · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
A web-based patient-reported symptom monitoring and self-management portal for adolescent and young adult breast cancer survivors
Michelle J. Naughton · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
NMR Fingerprinting: Leveraging optimal control pulse design, tailored isotope labeling, and machine learning to study intractable proteins
Haribabu Arthanari · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · research · R01
The role of NCOA4-mediated ferritinophagy in iron homeostasis and ferroptosis
Joseph D Mancias · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2023 · research · R21
Tools for DUB Drug Discovery
Sara J Buhrlage · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2025 · career development · K08
Regulating proliferation and differentiation of erythroid progenitors
Hojun Li · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2026 · research · R01
Mouse models of Kras-mutant colorectal cancer
Kevin Haigis · Dana-Farber Cancer Institute · funded by National Institutes of Health
2020–2022 · career development · K99
Uncovering Principles of Adaptive Regulation in Cancer Resistance Through Deep Evolutionary Profiling
Arvind Ravi · Dana-Farber Cancer Institute · funded by National Institutes of Health
